AC
BKYI

Armistice Capital’s BIO-key International BKYI Stock Holding History

Armistice Capital’s Portfolio BKYI Stock Details BKYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,046
Closed -$348K – 213
2025
Q1 		$348K Buy
+44,046
New +$560K 0.01% 187
2024
Q4 		– Sell
-25,000
Closed -$240K – 241
2024
Q3 		$240K Buy
+25,000
New +$360K ﹤0.01% 211
2024
Q1 		– Sell
-6,533
Closed -$196K – 347
2023
Q4 		$196K Buy
+6,533
New +$285K ﹤0.01% 239

Other funds holding BKYI

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Armistice Capital's BKYI Position: Q2 2025 in Review

Armistice Capital sold out of BIO-key International (BKYI) in Q2 2025, closing a stake of 44,046 shares — an estimated $348K sold.

Armistice Capital first reported a position in BKYI in Q4 2023 and held it in 3 quarters. The position peaked at $348K in Q1 2025. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2025.

  • Armistice Capital reported no remaining BIO-key International position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 44,046 BIO-key International shares in Q2 2025, an estimated $348K.
  • Armistice Capital first reported a position in BIO-key International in Q4 2023 and held it in 3 quarters.
  • Armistice Capital's BIO-key International position peaked at $348K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.